FIDELMED
ActiveSummary
The annual accounts of FIDELMED for fiscal year 2025 show a net loss of 54% of total assets. The 2025 annual accounts show equity of €636,115 and a net result of -€1.7m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 23% of 5113 sector peers (fiscal year 2025). The company has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability0=
Solvency46▲+32
Growth52▲+20
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25,000 at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity tight (current ratio 1.37 against 1.32 in 2024; short-term debt: 57.9% and cash: 13.7% of total assets), and 79.3% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 5113 sector peers (2025).
NBB · sector comparisonPosition among 5113 sector peers
Solvency
better than 23%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
8 d early
2024
173 d late
2023
121 d late
2022
487 d late
2021
2 d early
2020
1 d early
2019
66 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 119 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 30 November (4 of the last 5 filed years within 130 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€1.7m▼ 19.4%
2024 · -€1.4m
Working capital
€665,205▲ 51.6%
2024 · €438,874
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result-€357,839▲ 27.5%-€342,040▲ 4.4%-€511,497▼ 49.5%-€1.4m▼ 169%-€1.6m▼ 18.8%
Net result-€360,638below the sector's middle half▲ 28.1%-€333,002below the sector's middle half▲ 7.7%-€517,229below the sector's middle half▼ 55.3%-€1.4mbelow the sector's middle half▼ 169%-€1.7mbelow the sector's middle half▼ 19.4%
Equity-€486,842below the sector's middle half▼ 286%-€594,843below the sector's middle half▼ 22.2%€1.1mwithin the sector's middle half-€268,413below the sector's middle half€636,115within the sector's middle half
Total assets€648,993within the sector's middle half▼ 22.9%€471,590below the sector's middle half▼ 27.3%€2.0mwithin the sector's middle half▲ 317%€2.4mwithin the sector's middle half▲ 19.8%€3.1mwithin the sector's middle half▲ 30.4%
Debt€1.1m▲ 17.3%€1.1m▼ 6.1%€841,273▼ 21.1%€2.6m▲ 212%€2.4m▼ 7.2%
Working capital-€625,439below the sector's middle half▼ 263%-€709,971below the sector's middle half▼ 13.5%€1.0mabove the sector's middle half€438,874within the sector's middle half▼ 56.3%€665,205within the sector's middle half▲ 51.6%
Solvency-75.0%below the sector's middle half▼ 60.0pp-126.1%below the sector's middle half▼ 51.1pp57.2%within the sector's middle half▲ 183.3pp-11.4%below the sector's middle half▼ 68.6pp20.7%below the sector's middle half▲ 32.1pp
Current ratio0.44below the sector's middle half▼ 0.360.33below the sector's middle half▼ 0.112.76within the sector's middle half▲ 2.431.32within the sector's middle half▼ 1.441.37within the sector's middle half▲ 0.06
Return on assets (ROA)-55.6%below the sector's middle half▲ 4.0pp-70.6%below the sector's middle half▼ 15.0pp-26.3%below the sector's middle half▲ 44.3pp-59.2%below the sector's middle half▼ 32.8pp-54.2%below the sector's middle half▲ 5.0pp
Staff (FTE)2.4within the sector's middle half▼ 50.0%1below the sector's middle half▼ 58.3%0.1below the sector's middle half▼ 90.0%1.9within the sector's middle half▲ 1,800%3.3below the sector's middle half▲ 73.7%
above
within
below
the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €1.6m in 2025 against €1.4m in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.1m
Fixed assets
€625,987 ▲ 16.0%
Current assets
€2.4m ▲ 34.7%
Equity and liabilities €3.1m
Equity
€636,115
Debt
€2.4m
Debt finances 79.3% of the balance-sheet total.
Key figures and ratios
EBITDA
-€1.5m▼
2024 · -€1.3m
Cash flow
-€1.6m▼
2024 · -€1.3m
Quick ratio
1.28▲
2024 · 1.23
Debt to equity
3.83
ROE
-261.4%
Interest coverage
-50.30▲
2024 · -55.83
Debt ≤ 1 year
€1.8m▲
2024 · €1.4m
Debt > 1 year
€653,522▼
2024 · €1.2m
Income taxes
€732▼
2024 · €2,124
Staff costs
€206,561▲
2024 · €84,891
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 1,133 companies that looked in July 2024 the way this one looks now, 6.4% went bankrupt within 24 months and 86% are still going.
- Micro
- 5 to 10 years old
- solvency 10 to 30%
- a loss of 10% of the balance sheet or more
6.4%
went bankrupt
6.6%
stopped otherwise
86%
still going
A further 0.5% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.6% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 1,133 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €32,186 | €0 | - | - | - |
| Remuneration, social security and pensions62 | €113,843 | €8,223 | €4,168 | €84,891 | €206,561 | ▲ 143% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €41,042 | €44,059 | €46,726 | €78,342 | €89,660 | ▲ 14.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | €431 | €8,713 | ▲ 1,923% |
| Other operating charges640/8 | €3,374 | €2,094 | €1,267 | €35,086 | €4,386 | ▼ 87.5% |
| Non-recurring operating charges66A | - | €197,243 | €0 | - | - | - |
| Gross operating margin9900 | -€199,580 | -€90,421 | -€459,336 | -€1.2m | -€1.3m | ▼ 12.6% |
| Operating profit (loss)9901 | -€357,839 | -€342,040 | -€511,497 | -€1.4m | -€1.6m | ▼ 18.8% |
| Financial income75/76B | €1,323 | €20,415 | €4,577 | €8,677 | €3,970 | ▼ 54.2% |
| Recurring financial income75 | €1,323 | €20,415 | €4,577 | €8,677 | €3,970 | ▼ 54.2% |
| Financial charges65/66B | €4,008 | €11,376 | €10,307 | €23,247 | €30,724 | ▲ 32.2% |
| Recurring financial charges65 | €4,008 | €11,376 | €10,307 | €23,247 | €30,724 | ▲ 32.2% |
| Profit (loss) for the period before taxes9903 | -€360,525 | -€333,002 | -€517,227 | -€1.4m | -€1.7m | ▼ 19.5% |
| Income taxes67/77 | €113 | €0 | €2 | €2,124 | €732 | ▼ 65.5% |
| Profit (loss) for the period9904 | -€360,638 | -€333,002 | -€517,229 | -€1.4m | -€1.7m | ▼ 19.4% |
| Profit (loss) for the period to be appropriated9905 | -€360,638 | -€333,002 | -€517,229 | -€1.4m | -€1.7m | ▼ 19.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €648,993 | €471,590 | €2.0m | €2.4m | €3.1m | ▲ 30.4% |
| Fixed assets21/28 | €152,730 | €115,143 | €392,884 | €539,858 | €625,987 | ▲ 16.0% |
| Intangible fixed assets21 | €128,324 | €86,906 | €141,943 | €271,868 | €361,072 | ▲ 32.8% |
| Tangible fixed assets22/27 | €4,156 | €7,988 | €11,569 | €26,706 | €22,281 | ▼ 16.6% |
| Plant, machinery and equipment23 | €3,546 | €1,802 | €3,222 | €7,394 | €7,531 | ▲ 1.8% |
| Furniture and vehicles24 | €610 | €302 | €9 | €11,935 | €8,333 | ▼ 30.2% |
| Other tangible fixed assets26 | - | €5,883 | €8,337 | €7,377 | €6,417 | ▼ 13.0% |
| Financial fixed assets28 | €20,250 | €20,250 | €239,372 | €241,284 | €242,633 | ▲ 0.6% |
| Current assets29/58 | €496,262 | €356,447 | €1.6m | €1.8m | €2.4m | ▲ 34.7% |
| Stocks and contracts in progress3 | €197,243 | €0 | €3,455 | €124,769 | €174,709 | ▲ 40.0% |
| Stocks30/36 | €197,243 | €0 | €3,455 | €124,769 | €174,709 | ▲ 40.0% |
| Amounts receivable within one year40/41 | €229,842 | €285,861 | €673,541 | €1.6m | €1.8m | ▲ 16.3% |
| Trade receivables40 | €45,512 | €51,964 | €28,633 | €255,048 | €257,290 | ▲ 0.9% |
| Other amounts receivable41 | €184,330 | €233,898 | €644,908 | €1.3m | €1.6m | ▲ 19.2% |
| Cash at bank and in hand54/58 | €64,208 | €63,278 | €881,156 | €100,351 | €421,418 | ▲ 320% |
| Deferred charges and accrued income490/1 | €4,970 | €7,308 | €14,812 | €10,666 | €12,063 | ▲ 13.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €648,993 | €471,590 | €2.0m | €2.4m | €3.1m | ▲ 30.4% |
| Equity10/15 | -€486,842 | -€594,843 | €1.1m | -€268,413 | €636,115 | ▲ 337% |
| Contributions10/11 | €550,000 | €775,000 | €3.0m | €3.0m | €5.6m | ▲ 85.2% |
| Capital10 | €550,000 | €775,000 | €3.0m | €3.0m | €5.6m | ▲ 85.2% |
| Issued capital100 | €550,000 | €775,000 | €3.0m | €3.0m | €5.6m | ▲ 85.2% |
| Profit (loss) carried forward14 | -€1.0m | -€1.4m | -€1.9m | -€3.3m | -€4.9m | ▼ 50.7% |
| Amounts payable17/49 | €1.1m | €1.1m | €841,273 | €2.6m | €2.4m | ▼ 7.2% |
| Amounts payable after more than one year17 | €14,048 | €0 | €271,475 | €1.2m | €653,522 | ▼ 47.6% |
| Financial debts170/4 | €14,048 | €0 | €271,475 | €1.2m | €653,522 | ▼ 47.6% |
| Amounts payable within one year42/48 | €1.1m | €1.1m | €569,579 | €1.4m | €1.8m | ▲ 29.3% |
| Current portion of amounts payable after more than one year42 | €100,689 | €14,048 | €64,922 | €117,104 | €193,438 | ▲ 65.2% |
| Financial debts43 | €8,354 | €8,422 | €0 | - | - | - |
| Credit institutions430/8 | €8,354 | €8,422 | €0 | - | - | - |
| Trade debts44 | €92,023 | €72,389 | €96,551 | €765,747 | €1.5m | ▲ 93.3% |
| Suppliers440/4 | €92,023 | €72,389 | €96,551 | €765,747 | €1.5m | ▲ 93.3% |
| Advances received on contracts in progress46 | €30,537 | €19,095 | €0 | - | - | - |
| Taxes, remuneration and social security45 | €23,205 | €5,572 | €5,460 | €17,283 | €36,298 | ▲ 110% |
| Taxes450/3 | €13,836 | €647 | €536 | €2,099 | €7,591 | ▲ 262% |
| Remuneration and social security454/9 | €9,369 | €4,924 | €4,924 | €15,184 | €28,707 | ▲ 89.1% |
| Other amounts payable47/48 | €866,893 | €946,893 | €402,645 | €475,909 | €69,163 | ▼ 85.5% |
| Accrued charges and deferred income492/3 | €85 | €15 | €219 | €69 | €1,555 | ▲ 2,168% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€360,638 | -€333,002 | -€517,229 | -€1.4m | -€1.7m | ▼ 19.4% |
| + Depreciation and write-downs630 | €41,042 | €44,059 | €46,726 | €78,342 | €89,660 | ▲ 14.4% |
| Operating cash flow (approximation) | -€319,596 | -€288,943 | -€470,503 | -€1.3m | -€1.6m | ▼ 19.6% |
| Investment in fixed assets (approximation) | - | -€6,472 | -€324,467 | -€225,316 | -€175,789 | ▲ 22.0% |
| Change in cash | - | -€930 | €817,879 | -€780,805 | €321,066 | ▲ 141% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
17-08
State Gazette act
Reappointments: mediaxe, DECURA PHARMA and SPIDERWEBDeclaration6 facts ▸
State Gazette act
Reappointments: mediaxe, DECURA PHARMA and SPIDERWEB
Declaration6 facts ▸
- General meeting, 24-06-2026
- Director reappointment, mediaxe (director)
- Director reappointment, DECURA PHARMA (director)
- Declaration, mandate expiration and ratification, 27-06-2024
- Director reappointment, SPIDERWEB (director)
- Declaration, mandate expiration and ratification, 27-06-2024
23-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
20-01
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 173 days late
2025
31-12
Financial
Weakest financial yearnet -€1.7m
Net result drops to -€1.7m, the lowest in the series.
31-12
Financial
Equity above €500,000Eq €636,115
Equity rises from -€268,413 to €636,115.
2024
29-11
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 121 days late
29-11
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 487 days late
2023
31-12
Financial
Liquidity times 8current ratio 2.76
Current ratio from 0.33 to 2.76; short-term debt falls from €1.1m to €569,579.
31-12
Financial
Equity above €1mEq €1.1m
Equity rises from -€594,843 to €1.1m.
2022
29-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
05-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 66 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 11 acts read
About the unread acts
Of the 11 Belgian State Gazette acts we know for this company, 1 has been read. The other 10 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
under verification
This board is reconstructed from a single act (26353435). A Gazette act generally publishes only CHANGES, not a full roll call, so directors unchanged since then may be missing here. The KBO register holds the complete list of function holders.
DECURA PHARMA
CurrentDirector · Private limited company
mediaxe
CurrentDirector · Private limited company
SPIDERWEB
CurrentDirector · Private limited company (pre-2019)
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
10 of this company's 11 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2018
Ground area
9,704 m²
Building footprint
2,861 m²
Parcel 44038A0046/00C002, Flanders. Linked by address, not a title deed.
8
companies at this address
See who is registered here
1 establishment unit
Waalkens 11, 9030 Gent
since 20182.277.532.482
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44038A0046/00C002 | Flanders | 9,704 m² | 1 · 2,861 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
3 people since 2026, 3 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| DECURA PHARMA |
|
| mediaxe |
|
| SPIDERWEB |
|
Structure & network
Owners and holdings
3 owners · 1 holdingOwners 3
-
50%
-
0.94%
-
10 shares
Holdings 1
-
100%
According to the 2025 annual accounts of FIDELMED and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
3 current directorsThe group is listed under Ownership & control below; here you explore it as a network.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Recognitions · licences · registrations
Food safety, FASFC
1 siteGent2.277.532.482
Similar companies · same sector, comparable size
CERELO
BE 0883.004.361
Amel · Eq €637,233
R-SMOKING
BE 0872.342.576
Awans · Eq €639,286
ALEX ENEMAN
BE 0476.551.003
Wingene · Eq €632,757
PRO SCAN
BE 0899.775.364
Zonhoven · Eq €640,343
W M HOPITAL (B)
BE 0432.663.748
Mont-de-l'Enclus · Eq €631,709
Of 1,901 companies in this sector we hold annual accounts for 1,126. 780 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPublic limited company
Founded28-06-2018
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
58290Other software publishing
62900Other information technology and computer services
62200Computer consultancy and computer facilities management
E-invoicing
Reachable via Peppol
Peppol ID
0208:0698912120
Also
9925:BE0698912120
Registered
06-05-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.